KRUUSE PGA Suture, USP 0/EP 3.5, 90 cm/35.5", violet, 30 mm needle, 1/2 circle, round bodied, taper point, 12/pk

■ Suitable for subcutaneous and soft tissue surgery e.g. GI, urologic surgery, and orthopedic surgery where a midterm absorption profile is needed
■ USP 0
■ EP 3.5
■ Shape of needle: 1/2 circle, round bodied, taper point
■ Suture length: 90 cm / 35.5"
■ Needle length: 30 mm
■ Colour: Violet
■ 12/pk
■ Shelf life is 5 years (from production date)
KRUUSE PGA Suture is a synthetic, absorbable, multifilament, sterile surgical suture composed of polyglycolic acid and coated with polycaprolactone and calcium stearate.
Available dyed violet.
Complete mass absorption in 60-90 days (approximately 75% of original tensile strength 14 days after implantation, 40% of original tensile strength 21 days after implantation).

KRUUSE PGA Sutures are indicated for soft tissue approximation and ligation, where absorbable sutures are indicated, including:
■ Blood vessel ligation
■ Ductus ligation
■ Facia approximation
■ Gynaecology and abstretics
■ Joint capsula closure
■ Ligament ligation

KRUUSE PGA Suture is not intended for use in cardiovascular tissue, neurosurgery, or ophthalmic surgery.

Range in peel pack
USP 4-0 to 6
EP 1.5 to 8

Range in casettes
USP 3-0 to 6
EP 2 to 8

Sterilisation method: EO
Weight including packaging in kg 0,08
Barcode 5703188349125